Staxyn (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the Staxyn drug offered from GlaxoSmithKline LLC. This Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
| NON-PROPRIETARY NAME: | vardenafil hydrochloride |
| SUBSTANCE NAME: | VARDENAFIL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, ORALLY DISINTEGRATING |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-04-21 |
| END MARKETING DATE: | 0000-00-00 |
Staxyn HUMAN PRESCRIPTION DRUG Details:
| Item Description | Staxyn from GlaxoSmithKline LLC |
| LABELER NAME: | GlaxoSmithKline LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 11.85(mg/1) |
| START MARKETING DATE: | 2011-04-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0173-0822_36095c49-9046-4150-af0b-ac0e8435e066 |
| PRODUCT NDC: | 0173-0822 |
| APPLICATION NUMBER: | NDA200179 |
Other VARDENAFIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
